# OnCo record paper-ielsg32-wbrt-vs-asct-consolidation-ferreri-lancet-haematol-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ielsg32-wbrt-vs-asct-consolidation-ferreri-lancet-haematol-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ielsg32-wbrt-vs-asct-consolidation-ferreri-lancet-haematol-2017" ;
  schema:name "IELSG32 second randomisation: whole-brain radiotherapy or autologous stem cell transplant as consolidation in primary CNS lymphoma"@en ;
  schema:description "After chemotherapy for lymphoma of the brain, a stem cell transplant controlled the disease as well as radiotherapy to the whole brain, and spared patients the decline in attention and executive function that followed radiotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-ielsg32-wbrt-vs-asct-consolidation-ferreri-lancet-haematol-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S2352-3026(17)30174-6>, <https://pubmed.ncbi.nlm.nih.gov/29054815/> ;
  schema:sameAs <https://doi.org/10.1016/S2352-3026(17)30174-6> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Ferreri AJM, Cwynarski K, Pulczynski E, et al." ;
  onco:cancers <https://onco.cc/cancers/primary-cns-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/thiotepa/>, <https://onco.cc/drugs/carmustine/> ;
  onco:trials <https://onco.cc/trials/ielsg32/> ;
  onco:journals <https://onco.cc/journals/lancet-haematology/> .
